Miss a day, miss a lot. Subscribe to The Defender's Top News of the Day. It's free.

Student Gets Leg Amputated After COVID Vaccine, Dies of Brain Blood Clots

International Business Times reported:

A 20-year-old student whose leg was amputated after getting a COVID-19 vaccine has died of blood clots in the brain.

Ketsiree Kongkaew, who studied at Phangnga Community College in Thailand, died of a hemorrhagic stroke after brain surgery. The student had remained unconscious following the surgery and needed a ventilator to breathe. She was pronounced dead Monday.

The young woman, who had been admitted to the Songklanagarind Hospital, had previously gotten her left leg amputated after she developed blood clots following her second dose of COVID-19 vaccine, according to the Bangkok Post.

Fauci: ‘I Would Vaccinate Them in a Second’

Axios reported:

NIAID director Anthony Fauci tells Axios even though the chances of young children getting seriously ill from COVID-19 are small he urges parents to immunize them once a vaccine is authorized.

Driving the news: An FDA expert panel on Tuesday endorsed an emergency use authorization for a lower dose of Pfizer‘s COVID-19 vaccine for 5- to 11-year-olds, paving the way for another swath of the U.S. population to be vaccinated.

Most Parents Don’t Plan to Vaccinate Young Children Against COVID Right Away, KFF Survey Finds

CNN Health reported:

A COVID-19 vaccine could be available for little kids soon, and public health leaders say vaccinating them could help end the pandemic — but only if parents actually get them vaccinated.

A new survey suggests that’s uncertain at best.

The majority of parents say they will not get their younger children vaccinated right away, according to the survey published Thursday from the Kaiser Family Foundation.

Pfizer Gets U.S. Contract for 50 Million COVID Vaccine Doses for Kids

Reuters reported:

Pfizer Inc (PFE.N) and BioNTech SE (22UAy.DE) said on Thursday they expect to deliver 50 million more doses of their COVID-19 vaccine to the U.S. government by April-end, as the country prepares to vaccinate children.

The move comes after a panel of outside advisers to the U.S. Food and Drug Administration voted on Tuesday to recommend its authorization for the vaccine in children aged 5 to 11. The agency’s decision on the vaccine for the age group is awaited. read more

Will Kids Be Forced to Get a COVID Vaccine? | Opinion

Newsweek reported:

With the news that the Biden administration has purchased 65 million pediatric vaccine doses from Pfizer comes a pressing question: will kids be forced to get the COVID vaccine?

The vaccine was neither approved by the Food and Drug Administration (FDA), nor recommended by the Centers for Disease Control and Prevention (CDC), for pediatric use when the administration made its purchase. Meanwhile, states are already making policy around vaccinating children.

Arizona’s Attorney General Argues COVID Vaccines Not Properly Tested for Safety

Tucson reported:

In his legal dispute with the Biden administration over mandates, Attorney General Mark Brnovich is now raising questions about whether COVID-19 vaccines were properly tested for safety.

The latest version of his lawsuit filed in federal court says the process used by the FDA for full approval “has been significantly accelerated.’’

He cites the Centers for Disease Prevention and Control’s statement that vaccine licensing “is a lengthy process that can take 10 years or longer.’’

Why Even Some Vaccinated Parents Aren’t Planning to Rush to Give Kids COVID Shot

NBC News reported:

Sarah Beth Burwick, a lawyer in Los Angeles, said she and her husband both got their COVID-19 vaccinations at “the earliest possible opportunity” and their two children received all of their childhood vaccinations “on the schedule, without even questioning it.”

But she’s not planning to rush out to get the children, ages 5 and 2, vaccinated against COVID, even though one of them could be eligible as soon as next week.

“There would need to be information out there to convince us it was necessary first,” Burwick, 37, said. “I would say I think it’s unnecessary. And I’m uncomfortable with how quickly it’s rolling out with such a small study.”

Health Minister Insists Vaccination Not Beneficial for Children

Mexico News Daily reported:

Health Minister Jorge Alcocer has once again claimed that COVID-19 vaccines could inhibit the development of children’s immune systems.

Alcocer made the remarks a week and a half after claiming that vaccinating children against COVID-19 could have a “limiting” effect on the development of their immune systems. He said Tuesday that he wouldn’t vaccinate his grandchildren.

Conscript Dies Day After Second Vaccine Shot

Bangkok Post reported:

A 23-year-old army conscript died on Tuesday, one day after he received a second dose of COVID-19 vaccine, different from the first.

Khanti Anantasiri, who was based in Tak province, died at his home in Chom Bung district of Ratchaburi on Tuesday afternoon, one day after being inoculated with the AstraZeneca vaccine.

Khanti had no underlying health condition. He took leave from his camp, Oct. 22-28, to return home to get his second dose of vaccine, and was given Astra Zeneca. He was earlier given a first dose of Sinovac vaccine. The father said he believed his son died as a result of the vaccination. His son’s body was sent to Ratchaburi Hospital for an autopsy.

Jabs Do Not Reduce Risk of Passing COVID Within Household, Study Suggests

The Guardian reported:

People who are fully vaccinated against COVID yet catch the virus are just as infectious to others in their household as infected unvaccinated people, research suggests.

Now a study has revealed that while vaccination against COVID is crucial to preventing severe disease and death, even fully jabbed individuals catch the virus — and pass it on.

Cheap Antidepressant Shows Promise Treating Early COVID

Associated Press reported:

A cheap antidepressant reduced the need for hospitalization among high-risk adults with COVID-19 in a study hunting for existing drugs that could be repurposed to treat coronavirus.

Researchers tested the pill used for depression and obsessive-compulsive disorder because it was known to reduce inflammation and looked promising in smaller studies.

They’ve shared the results with the U.S. National Institutes of Health, which publishes treatment guidelines, and they hope for a World Health Organization recommendation.